Press Releases on September 13, 2023 - EIN Presswire - Press Release Distribution Service

Published on September 13, 2023 - 13:00 GMT

Curia unterstützt die klinische Studie der Phase 1 von Replicate Bioscience mit einem neuartigen RNA-Impfstoff der nächsten ...

ALBANY, N.Y., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Curia, ein führendes Auftragsforschungs-, Entwicklungs- und Produktionsunternehmen, gab heute bekannt, dass sein Partner Replicate Bioscience die IND-Freigabe von der FDA erhalten hat und der erste …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on September 13, 2023 - 13:00 GMT

Curia apoya el ensayo clínico de fase 1 de la novedosa vacuna de ARN de última generación de Replicate Bioscience

ALBANY, N.Y., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Curia, una organización líder en investigación, desarrollo y fabricación por contrato, ha anunciado hoy que su socio, Replicate Bioscience, ha recibido la autorización de la FDA a su solicitud de un nuevo …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on September 13, 2023 - 13:00 GMT

キュリア（Curia）、レプリケート・バイオサイエンス（Replicate Bioscience）の新規次世代RNAワクチン向け第一フェーズ臨床治験を支援

ニューヨーク、アルバニー, Sept. 13, 2023 (GLOBE NEWSWIRE) -- 研究開発・製造受託機関のリーダーであるキュリアは本日、同社のパートナーであるレプリケート・バイオサイエンスがFDAからINDの認可を受け、キュリアとの共同研究の一環として開発された臨床材料を使用した第一フェーズ臨床治験において、自己複製（srRNA）狂犬病ワクチンであるRBI-4000を最初の参加者に投与したと発表した。キュリアは、srRNA RBI-4000原薬のプロセス開発、規模拡張、cGMP …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on September 13, 2023 - 13:00 GMT

Curia soutient l'essai clinique de phase 1 de Replicate Bioscience sur un vaccin novateur à base d'ARN de nouvelle génération

ALBANY, ÉTAT DE NEW YORK, 13 sept. 2023 (GLOBE NEWSWIRE) -- Curia, une organisation de recherche, développement et fabrication en sous-traitance de premier plan, a annoncé aujourd'hui que son partenaire, Replicate Bioscience, a reçu une autorisation de …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on September 13, 2023 - 13:00 GMT

Curia Sokong Percubaan Klinikal Fasa 1 Replicate Bioscience bagi Novel Vaksin RNA Generasi Seterusnya

ALBANY, N.Y., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Curia, sebuah organisasi penyelidikan, pembangunan dan pembuatan kontrak terkemuka, hari ini mengumumkan bahawa rakan kongsinya, Replicate Bioscience, telah menerima pelepasan IND daripada FDA dan telah …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on September 13, 2023 - 13:00 GMT

Curia Mendukung Uji Klinis Fase 1 Vaksin RNA Generasi Terbaru dari Replicate Bioscience

ALBANY, N.Y., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Curia, perusahaan penelitian, pengembangan, dan manufaktur terkemuka berbasis kontrak, hari ini mengumumkan bahwa mitranya, Replicate Bioscience, telah menerima izin IND dari FDA serta telah memberikan dosis …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on September 13, 2023 - 13:00 GMT

Curia, 새로운 차세대 RNA 백신 개발하는 Replicate Bioscience의 1상 임상 지원

뉴욕 올버니, Sept. 13, 2023 (GLOBE NEWSWIRE) -- 선도적인 위탁연구개발생산(CRDMO) 업체인 Curia의 협력사 Replicate Bioscience가 FDA로부터 임상시험계획 승인신청(IND) 허가를 받았으며, Curia와 협력해 개발한 임상 물질을 활용한 1상 임상 연구에서 첫 번째 참가자에게 자기복제 RNA(srRNA) 광견병 백신 RBI-4000을 투약했다. Curia는 srRNA RBI-4000 원료 물질의 공정 …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on September 13, 2023 - 13:00 GMT

A Curia apoia o ensaio clínico de fase 1 da nova vacina de RNA de última geração da Replicate Bioscience

ALBANY, N.Y., Sept. 13, 2023 (GLOBE NEWSWIRE) -- A Curia, uma organização líder em pesquisa, desenvolvimento e fabricação por contrato, anunciou hoje que sua parceira, Replicate Bioscience, recebeu autorização IND da FDA e dosou o primeiro participante com …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on September 13, 2023 - 13:00 GMT

Curia สนับสนุนการทดลองทางคลินิกระยะที่ 1 ของวัคซีน RNA รุ่นใหม่ของ Replicate Bioscience

ออลบานี นิวยอร์ก, Sept. 13, 2023 (GLOBE NEWSWIRE) -- ในวันนี้ Curia องค์กรการวิจัย การพัฒนา และการผลิตตามสัญญาชั้นนำได้ว่า Replicate Bioscience ซึ่งเป็นพันธมิตรของบริษัท ได้รับการอนุมัติ IND จาก FDA และได้ให้ยาแก่ผู้เข้าร่วมรายแรกด้วย RBI-4000 …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on September 13, 2023 - 13:00 GMT

Curia 助力 Replicate Bioscience 新型下一代 RNA 疫苗的 I 期临床试验

纽约州奥尔巴尼, Sept. 13, 2023 (GLOBE NEWSWIRE) -- 领先的合同研究、开发和制造组织 Curia 今日宣布，其合作伙伴 Replicate Bioscience 已获得美国食品药品监督管理局 (FDA) 的研究性新药 (IND) 批准，并已在一项 I 期临床研究中为第一名参与者注射了 RBI-4000 自我复制 RNA (srRNA) 狂犬病疫苗，该研究使用了与 Curia 合作开发的临床材料。 Curia 进行了 srRNA RBI-4000 原料药的工艺开发、工艺放大和 …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on September 13, 2023 - 13:00 GMT

Curia 為 Replicate Bioscience 新型下一代 RNA 疫苗的一期臨床試驗提供支援

紐約州奧爾巴尼, Sept. 13, 2023 (GLOBE NEWSWIRE) -- 業界領先的合同研究、開發和製造組織 Curia 今天宣布，其合作夥伴 Replicate Bioscience 已獲得食品及藥物管理局 (FDA) 的研究性新藥 (IND) 許可，並已為第一位受試者注射了 RBI-4000，這是一種自我複製 RNA (srRNA) 狂犬病疫苗，正在進行一期臨床研究，其中有用到與 Curia 合作開發的臨床化學原料藥。 Curia 主導了 srRNA RBI-4000 …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on September 13, 2023 - 13:00 GMT

ZOOZ Power to Present Virtually at the Sidoti Small Cap Conference on September 20, 2023

LOD, Israel, Sept. 13, 2023 (GLOBE NEWSWIRE) -- ZOOZ Power (TASE: ZOOZ), a leading provider of flywheel-based power boosting solutions enabling ultra-green, ultra-fast electric vehicle charging anywhere, today announced that Boaz Weizer, Chief Executive …

Distribution channels:

Published on September 13, 2023 - 13:00 GMT

Surface Treatment Solutions Market for Aviation MRO to be Worth $750.1 Million by 2030—Exclusive Report by Meticulous Research®

Redding, California, Sept. 13, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled, ‘Surface Treatment Solutions Market for Aviation MRO by Surface Treatment (Anodizing Solutions, Chemical Treatment Solutions, Plating Solutions, …

Distribution channels:

Published on September 13, 2023 - 13:00 GMT

Scilex Holding Company Enters into Non-Binding Term Sheets for the Purchase of all of the Scilex Common Shares, Preferred Shares, ...

PALO ALTO, Calif., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), a majority-owned subsidiary of Sorrento Therapeutics, Inc. (OTC: SRNEQ, “Sorrento”), an innovative revenue-generating company focused on …

Distribution channels:

Published on September 13, 2023 - 13:00 GMT

Charting the Future of Data Storage: DSPA-Asia Bootcamp by GreaterHeat

Singapore, Sept. 13, 2023 (GLOBE NEWSWIRE) -- GreaterHeat, a Singapore-based AI and Web3 technology company, has concluded its highly successful Second Cohort of the Decentralized Storage Providers Accelerator Asia (DSPA-Asia) Bootcamp from September 11-12 …

Distribution channels:

Published on September 13, 2023 - 13:00 GMT

NBA Blast Celebrates Significant Growth And Success In The Digital Basketball Sphere

Legnica, Poland, Sept. 13, 2023 (GLOBE NEWSWIRE) -- NBA Blast, a leading online platform dedicated to all things basketball and NBA, is thrilled to announce it is celebrating achieving significant growth and success in the digital basketball sphere the …

Distribution channels:

Published on September 13, 2023 - 12:59 GMT

Yoga Gives Back Announces Ambassadors of the Year 2023

To Be Recognized at the Annual Gala LOS ANGELES, CALIFORNIA, USA, September 13, 2023 /⁨EINPresswire.com⁩/ -- Yoga Gives Back’s global community of Ambassadors is the key to our grassroots outreach who are now 150 Ambassadors strong in over 20 …

Distribution channels: Culture, Society & Lifestyle, Human Rights ...

Published on September 13, 2023 - 12:59 GMT

TomaGold Corporation Receives Approval for Option of Chibougamau Independent’s West Block and LOI on East Block

ROUYN-NORANDA, Québec, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Chibougamau Independent Mines Inc. (“Chibougamau”) (CBG-TSX-V in Canada, CLL1-Frankfurt, Stuttgart and Lang & Schwarz Stock Exchanges in Germany, CMAUF-OTC in the US) is pleased to announce that …

Distribution channels:

Published on September 13, 2023 - 12:59 GMT

HHS Secretary Xavier Becerra Declares Public Health Emergency for Georgia

Today, U.S. Department of Health and Human Services (HHS) Secretary Xavier Becerra declared a Public Health Emergency (PHE) for the state of Georgia to address the health impacts of Hurricane Idalia. The declaration follows President Biden’s emergency …

Distribution channels:

Published on September 13, 2023 - 12:59 GMT

Fareportal receives Million Dollar Sales Award from China Airlines

New York, New York, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Leading travel technology company Fareportal was recently awarded the Million Dollar Sales Award from China Airlines recognizing exceptional performance by the company’s online travel agency brands, …

Distribution channels: